Mediation of β-endorphin in andrographolide-induced plasma glucose-lowering action in type I diabetes-like animals

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 377, Issue 4-6, 2008, Pages 529-540

  Yu, Bu Chin ^a   Chang, Cheng Kuei ^b   Su, Chih Fen ^c   Cheng, Juei Tang ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL TAINAN INSTITUTE OF NURSING   (Taiwan)

Author keywords

Endorphin; Andrographolide; Opioid receptor; STZ diabetic rats

Indexed keywords

5 CHLORO N [2 (2 CYCLOPROPYLMETHOXYPHENOXY)ETHYL] ALPHA,ALPHA DIMETHYL 1H INDOLE 3 ETHANAMINE; ALPHA 1 ADRENERGIC RECEPTOR; ANDROGRAPHOLIDE; BETA ENDORPHIN; GLUCOSE; GLUCOSE TRANSPORTER 4; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR ANTAGONIST; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PRAZOSIN;

ADRENAL MEDULLA; ADRENALECTOMY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; ENZYME LOCALIZATION; GLUCOSE BLOOD LEVEL; IMMUNOREACTIVITY; INSULIN DEPENDENT DIABETES MELLITUS; KNOCKOUT MOUSE; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; STREPTOZOCIN DIABETES;

ANIMALS; BETA-ENDORPHIN; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DITERPENES; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; GLUCOSE TRANSPORTER TYPE 4; HYPOGLYCEMIC AGENTS; LIVER; MALE; MICE; MICE, KNOCKOUT; MUSCLE, SKELETAL; RATS; RATS, WISTAR; RECEPTORS, OPIOID, MU; STREPTOZOCIN;

EID: 45849092979     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-007-0240-0     Document Type: Conference Paper

References (37)

1. Ableitner A, Schulz R (1992) Neuroanatomical sites mediating the central actions of beta-endorphin as mapped by changes in glucose utilization: involvement of mu opioid receptors. J Pharmacol Exp Ther 262:415-423
2. Berger J, Biswas C, Vicario PP, Strout HV, Saperstein R, Pilch PF (1989) Decreased expression of the insulin-responsive glucose transporter in diabetes and fasting. Nature 340:70-72
3. Chen WC, Hayakawa S, Yamamoto T, Su HC, Liu IM, Cheng JT (2004) Mediation of beta-endorphin by the isoflavone puerarin to lower plasma glucose in streptozotocin-induced diabetic rats. Planta Med 70:113-116
4. Cheng JT, Liu IM, Chi TC, Tzeng TF, Lu FH, Chang CJ (2001a) Plasma glucose-lowering effect of tramadol in streptozotocin-induced diabetic rats. Diabetes 50:2815-2821
5. Cheng JT, Liu IM, Kuo DH, Lin MT (2001b) Stimulatory effect of phenylephrine on the secretion of β-endorphin from rat adrenal medulla in vitro. Auton Neurosci 93:31-35
6. Cheng JT, Liu IM, Tzeng TF, Tsai CC, Lai Y (2002) Plasma glucose lowering effect of β-endorphin in streptozotocin-induced diabetic rats. Horm Metab Res 34:570-576
7. Consoli A, Nurjhan N, Capani F, Gerich J (1989) Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM. Diabetes 38:550-557
8. Curry DL, Li CH (1987) Stimulation of insulin secretion by beta-endorphin (1-27 and 1-31). Life Sci 40:2053-2058
9. Evans AA, Smith ME (2004) Opioid receptors in fast and slow skeletal muscles of normal and dystrophic mice. Neurosci Lett 366:339-341
10. Evans AA, Khan S, Smith ME (1997) Evidence for a hormonal action of beta-endorphin to increase glucose uptake in resting and contracting skeletal muscle. J Endocrinol 155:387-392
11. Evans AA, Tunnicliffe G, Knights P, Bailey CJ, Smith ME (2001) Delta opioid receptors mediate glucose uptake in skeletal muscles of lean and obese-diabetic (ob/ob) mice. Metabolism 50:1402-1408
12. 12 cells. Planta Med 70:1230-1233
13. Khamaisi M, Potashnik R, Tirosh A, Demshchak E, Rudich A, Tritschler H, Wessel K, Bashan N (1997) Lipoic acid reduces glycemia and increases muscle GLUT4 content in streptozotocin-diabetic rats. Metabolism 46:763-768
14. Khamaisi M, Rudich A, Potashnik R, Tritschler HJ, Gutman A, Bashan N (1999) Lipoic acid acutely induces hypoglycemia in fasting nondiabetic and diabetic rats. Metabolism 48:504-510
15. Khan S, Evans AA, Hughes S, Smith ME (2005) Beta-endorphin decreases fatigue and increases glucose uptake independently in normal and dystrophic mice. Muscle Nerve 31:481-486
16. Kilpatrick DL, Lewis RV, Stein S, Udenfriend S (1980) Release of enkephalins and enkephalin-containing polypeptides from perfused beef adrenal glands. Proc Natl Acad Sci USA 77:7473-7475
17. Hughes S, Smith ME, Bailey CJ (1992a) Beta-endorphin and corticotropin immunoreactivity and specific binding in the neuromuscular system of obese-diabetic mice. Neuroscience 48:463-468
18. Hughes S, Smith ME, Bailey CJ (1992b) POMC-derived peptides in the neuromuscular system of streptozotocin-diabetic mice. Peptides 13:873-877
19. Hwang SL, Liu IM, Tzeng TF, Cheng JT (2005) Activation of imidazoline receptors in adrenal gland to lower plasma glucose in streptozotocin-induced diabetic rats. Diabetologia 48:767-775
20. Jeffcoate SL (2004) Diabetes control and complications: the role of glycated haemoglobin 25 years on. Diabet Med 21:657-665
21. Johansen O, Vaaler S, Jorde R, Reikeras O (1994) Increased plasma glucose levels after Hypnorm anaesthesia, but not after Pentobarbital anaesthesia in rats. Lab Anim 28:244-248
22. Lindstrom J, Louheranta A, Mannelin M, Rastas M, Salminen V, Eriksson J, Uusitupa M, Tuomilehto J (2003) The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care 26:3230-3236
23. Liu IM, Chi TC, Chen YC, Lu FH, Cheng JT (1999) Activation of opioid mu-receptor by loperamide to lower plasma glucose in streptozotocin-induced diabetic rats. Neurosci Lett 265:183-186
24. Liu IM, Chen WC, Cheng JT (2003) Mediation of beta-endorphin by isoferulic acid to lower plasma glucose in streptozotocin-induced diabetic rats. J Pharmacol Exp Ther 307:1196-1204
25. Loh HH, Liu HC, Cavalli A, Yang W, Chen YF, Wei LN (1998) Opioid μ receptor knockout in mice: effects on ligand-induced analgesia and morphine lethality. Brain Res Mol Brain Res 54:321-326
26. Packer L (1994) Antloxidant properties of lipoic acid and its therapeutic effects in prevention of diabetes complications and cataracts. Ann NY Acad Sci 738:257-264
27. Panossian A, Hovhannisyan A, Mamikonyan G, Abrahamian H, Hambardzumyan E, Gabrielian E, Goukasova G, Wikman G, Wagner H (2000) Pharmacokinetic and oral bioavailability of andrographolide from Andrographis paniculata fixed combination Kan Jang in rats and humans. Phytomedicine 7:351-364
28. Pasternak GW (1993) Pharmacological mechanisms of opioid analgesics. Clin Neuropharmacol 16:1-18
29. Shen YC, Chen CF, Chiou WF (2002) Andrographolide prevents oxygen radical production by human neutrophils: possible mechanism(s) involved in its anti-inflammatory effect. Br J Pharmacol 135:399-406
30. Trivedi NP, Rawal UM (2001) Hepatoprotective and antioxidant property of Andrographis paniculata (Nees) in BHC induced liver damage in mice. Indian J Exp Biol 39:41-46
31. Trivedi NP, Rawal UM, Patel BP (2007) Hepatoprotective effect of andrographolide against hexachlorocyclohexane-induced oxidative injury. Integr Cancer Ther 6:271-280
32. Vargo T, Rossier J, Minick S, Ling N, Rivier C, Vale W, Bloom F (1977) β-Endorphin and adrenal corticotropin are secreted concomitantly by the pituitary gland. Science 197:1367-1369
33. Wohaieb SA, Godin DV (1987) Alterations in free radical tissue-defense mechanisms in streptozotocin-induced diabetes in rat. Effect of insulin treatment. Diabetes 36:1014-1018
34. Yu BC, Hung CR, Chen WC, Cheng JT (2003) Antihyperglycemic effect of andrographolide in streptozotocin-induced diabetic rats. Planta Med 69:1075-1079
35. Zhang XF, Tan BK (2000a) Antihyperglycaemic and anti-oxidant properties of Andrographis paniculata in normal and diabetic rats. Clin Exp Pharmacol Physiol 27:358-363
36. Zhang XF, Tan BK (2000b) Anti-diabetic property of ethanolic extract of Andrographis paniculata in streptozotocin-diabetic rats. Acta Pharmacol Sin 21:1157-1164
37. Zimmet P, Alberti KG, Shaw J (2001) Global and societal implications of the diabetes epidemic. Nature 414:782-787